Detroit Tigers legend Kirk Gibson will be joined by members of the Kirk Gibson Foundation for Parkinson’s Board of Directors ...

BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative ...

A new study finds sleeping on your back could increase your risk for neurodegenerative disorders, such as Alzheimer’s disease ...

Parkinson's comes on slowly, and diagnosing the often-devastating movement disorder, particularly in its early stages, ...

H.C. Wainwright analyst Emily Bodnar maintained a Hold rating on Ventyx Biosciences (VTYX – Research Report) today and set a price target ...

The Sanofi equity investment means the Big Pharma will receive exclusive rights of first negotiation surrounding VTX3232, an ...

Sanofi invests $27 million in Ventyx Biosciences at $3.8243 per share. The investment will fund VTX3232 trials for ...

BOSTON, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, announced that Craig Thompson, chief ...

A study using a tiny roundworm could pave the way for new treatments for neurodegenerative disorders. Researchers linked the worm gene swip-10 to copper regulation -- a vital element for brain health ...

“Our discovery of RORB for these selectively vulnerable cells gives us the opportunity to study in detail exactly why they ...

We look forward to strengthening our relationship with Sanofi as the VTX3232 clinical programs progress, with data from the Phase 2a trial in patients with early Parkinson’s disease and data from the ...

A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...